Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 10/20 | 0.69 |
| ▸ | GNAI1 | P63096 | 10/20 | 0.69 |
| ▸ | GNAO1 | P09471 | 9/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | NAAA | Q02083 | 2/20 | 0.54 |
| ▸ | FAAH | O00519 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9120685 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL9658815 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL18651303 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL6488462 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL3601270 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL23533349 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL8973027 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL8972999 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL8973060 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 | |
| SCHEMBL9415674 | 1.00 | GNAI3 (0.69) | GNAI3GNAI1GNAO1L3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023017484-A1 | CYTOTOXICITY TARGETING CHIMERAS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2023-02-16 | — | — | WO | disclosed |
| US-9120846-B2 | Neutral zwitterionic displacer molecules for hydrophobic displacement chromatography | SACHEM, INC. (US) | 2015-09-01 | — | — | US | disclosed |
| US-20140256910-A1 | NEUTRAL ZWITTERIONIC DISPLACER MOLECULES FOR HYDROPHOBIC DISPLACEMENT CHROMATOGRAPHY | PNC BANK, NATIONAL ASSOCIATION | 2014-09-11 | — | — | US | disclosed |
| WO-2010138820-A2 | N,N-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-12-02 | — | — | WO | disclosed |
| US-6746985-B2 | COMPRISES DIAZO COMPOUND FOR COLOR-DEVELOPMENT | FUJI PHOTO FILM CO., LTD. (JP) | 2004-06-08 | — | — | US | disclosed |
| US-20030138720-A1 | Multicolor heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. | 2003-07-24 | — | — | US | disclosed |
| US-20030104939-A1 | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. | 2003-06-05 | — | — | US | disclosed |
| EP-1253022-A1 | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. (JP) | 2002-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256910-A1 | NEUTRAL ZWITTERIONIC DISPLACER MOLECULES FOR HYDROPHOBIC DISPLACEMENT CHROMATOGRAPHY | SLCO4C1, SLCO2A1, SLCO2B1 | GNAI3 2079/4885GNAI1 2655/4885GNAO1 320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.